COMPLETED

THRIVE: Culturally AdapTed Harm Reduction Intervention

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to develop and test a culturally adapted harm reduction intervention among Black adults who misuse opioids and/or stimulants. The questions it aims to answer include: will the culturally adapted harm reduction educational intervention increase overall knowledge of overdose and prevention/intervention techniques and increase confidence and willingness to use/teach interventions to others at-risk.

Official Title

Culturally AdapTed Harm Reduction Intervention: Community Engaged InterVention for Black Adults That MisusE Opioids and Stimulants

Quick Facts

Study Start:2025-04-02
Study Completion:2025-06-20
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06609278

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Identify as Black or African American
  2. * Currently a resident of study areas
  3. * Report misuse of stimulants and/or opioids in the last six months
  1. * Do not identify as Black or African American
  2. * If they participated in Aim 1 of the study
  3. * Do not want to be audio-recorded

Contacts and Locations

Principal Investigator

Brittany Miller-Roenigk, PhD
PRINCIPAL_INVESTIGATOR
University of Kentucky

Study Locations (Sites)

Louisville Central Community Center
Louisville, Kentucky, 40203
United States
Urban Minority Alcoholism and Drug Abuse Outreach Program (UMADAOP) of Cincinnati
Cincinnati, Ohio, 45219
United States
University of Cincinnati
Cincinnati, Ohio, 45221
United States

Collaborators and Investigators

Sponsor: Brittany Miller-Roenigk

  • Brittany Miller-Roenigk, PhD, PRINCIPAL_INVESTIGATOR, University of Kentucky

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-02
Study Completion Date2025-06-20

Study Record Updates

Study Start Date2025-04-02
Study Completion Date2025-06-20

Terms related to this study

Keywords Provided by Researchers

  • Harm Reduction
  • Opioid Overdose
  • Stimulant Misuse
  • Opioid Misuse
  • Narcan
  • Fentanyl Test Strips

Additional Relevant MeSH Terms

  • Opioid Use
  • Stimulant Use